MedPath

辽宁海一制药有限公司

Ownership
-
Established
2014-05-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

NMPA:37

Drug Approvals

肿节风咀嚼片

Approval Number
国药准字Z20080177
Approval Date
Mar 10, 2023
NMPA

Vitacoenzyme Capsules

Product Name
维酶素胶囊
Approval Number
国药准字H20045583
Approval Date
Aug 10, 2020
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H20045574
Approval Date
Aug 10, 2020
NMPA

Inosine Capsules

Product Name
肌苷胶囊
Approval Number
国药准字H20045573
Approval Date
Aug 10, 2020
NMPA

Albendazole Capsules

Product Name
阿苯达唑胶囊
Approval Number
国药准字H20045572
Approval Date
Aug 10, 2020
NMPA

Piracetam Capsules

Product Name
吡拉西坦胶囊
Approval Number
国药准字H20045581
Approval Date
Aug 10, 2020
NMPA

Lincomycin Hydrochloride Capsules

Product Name
盐酸林可霉素胶囊
Approval Number
国药准字H20045577
Approval Date
Aug 10, 2020
NMPA

肝速康胶囊

Approval Number
国药准字Z19993229
Approval Date
Jul 23, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H21021971
Approval Date
Jul 23, 2020
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and Chlorphenamine Maleate Tablets

Product Name
氨咖黄敏片
Approval Number
国药准字H21023337
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy